Latest Distributions News

BrainChip Holdings has moved its AKD1500 neuromorphic AI chip into volume production, supported by key supply agreements and expanded distribution channels, while maintaining a stable cash position.

Franklin Templeton Australia has launched the Franklin Australian Absolute Return Bond Fund – Class A, an actively managed fixed income fund now available on the ASX. The fund aims to deliver returns exceeding the Bloomberg AusBond Bank Bill Index with a medium risk profile and transparent fee structure.

Icetana Limited reports a strategic pivot to a SaaS-driven revenue model with recurring income now dominating its sales, despite a 49% drop in total revenue for FY25. A landmark partnership with SoftBank Robotics aims to fuel growth in Japan and beyond.

Franklin Templeton Australia has launched the Franklin Global Growth Fund – Class A, an actively managed ETF listed on the ASX aiming to outperform the MSCI World ex Australia Index with a strong ESG commitment and a 0.90% management fee.

Fintech firm 8common has kicked off FY26 with an 8% rise in SaaS and transaction revenue, positive operational cashflow, and a renewed multi-year government contract.

Savannah Goldfields Limited has reported promising high-grade gold intercepts from recent drilling at its Electric Light Prospect in North Queensland, with plans for further exploration and metallurgical testing underway.

Fortuna Metals is advancing exploration at its Mkanda and Kampini projects in Malawi, aiming to define a significant rutile resource by late 2026. Early drilling and sampling have revealed encouraging titanium mineralisation, positioning the company in a globally critical minerals hotspot.

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.

Audeara Ltd has reported a remarkable 111% revenue increase in Q1 FY26, driven by strong growth in its technology division and key international partnerships in China and Japan. The company is advancing towards cashflow breakeven with improved cash management and expanding global reach.

Firebrick Pharma reports a $1.94 million cash reserve after a $1.4 million placement, supporting expanded Nasodine sales across Southeast Asia and the US. Board changes and increased operational costs mark a pivotal quarter for the pharmaceutical innovator.

St George Mining’s latest diamond drilling results at the Araxá Project confirm a significant westward extension of high-grade rare earth and niobium mineralisation, reinforcing the potential for a major resource upgrade.

Brazilian Critical Minerals has successfully produced a high-grade mixed rare earth carbonate containing 50% total rare earth oxides from low-grade field leach solutions at its Ema Project, validating its in-situ recovery process and commercial viability.